Key result
Diuretic omission for 48 hours increases LVEDV by ~8 mL without altering ultrasound congestion markers.
Why the study?
Congestion worsens symptoms, signs, and prognosis in HF, and identifying it earlier might allow timely interventions. This study assessed the feasibility of using ultrasound to identify and quantify changes in interstitial and intravascular congestion following temporary diuretic suspension in patients with HF.
Does a 48-hour suspension of diuretics produce detectable changes in ultrasound markers of interstitial and intravascular congestion and cardiac volumes in patients with heart failure?
RCT (n=20)
Open-label (with blinded ultrasound image analysis)
randomised cross-over to the order of 48-hour diuretic omission vs usual treatment
Does a 48-hour suspension of diuretics produce detectable changes in ultrasound markers of interstitial and intravascular congestion and cardiac volumes in patients with heart failure?
A 48-hour withdrawal of diuretics in stable heart failure patients leads to subclinical increases in left ventricular and left atrial volumes detectable by echocardiography before changes occur in NT-proBNP, weight, or extra-cardiac ultrasound congestion markers.
Answers are grounded in this paper and cite their sources.
Even brief diuretic omission enlarges LV and LA volumes on echo before other markers change; extends sensitive imaging for subclinical HF monitoring.
Background Symptoms and signs of heart failure (HF), and prognosis, are worsened by congestion. Identifying congestion at earlier stages might allow for timely interventions, leading to delays in progression of HF, improved well-being and clinical outcomes. Purpose To assess the feasibility of using ultrasound (US) to identify and quantify changes in interstitial and intravascular congestion, following temporary suspension of diuretics in patients with HF. Methods This is an open-label, randomised cross-over trial, comprising two 48-hour study investigation periods, separated by an interval of at least one week. We enrolled consenting adults with a clinical diagnosis of HF, on guideline-recommended HF therapy including a loop diuretic, whose NT-proBNP was >125ng/L. Key exclusion criteria were atrial fibrillation (AF), estimated glomerular filtration rate (eGFR) <30ml/min/1.73m2, significant valve disease, or a likelihood of poor tolerability of a 48-hour omission of diuretics. Patients were randomised to the order in which their existing prescribed loop diuretics and mineralocorticoid receptor antagonist (MRA), if taking one, would be either omitted for 48 hours prior to the study visit, or taken as usual over this period. On the morning of each study visit, participants were asked to omit that morning dose. During each study visit, after clinical evaluation, participants had blood samples taken, an echocardiogram, and ultrasonographic assessment of lung, renal and inferior vena cava and internal jugular congestion. All ultrasound images were analysed by the same cardiologist, who was blinded to the order of the study visits, clinical and laboratory findings. Results We enrolled 20 patients (median age 72 (65-77) years, median NT-proBNP 343 (239-618) ng/L, median left ventricular ejection fraction (LVEF) 45 (40-50)%). Omission of diuretics for 48 hours led to increases in left ventricular end diastolic volume (LVEDV; 8.4ml, 0.8 to 16.0ml, p=0.03), left ventricular end systolic volume (LVESV; 5.7ml, 1.0 to 10.4ml, p=0.02) and max left atrial volume (LAV), (4.9ml, 0.5 to 9.2ml, p=0.03). There were no significant changes in NT-proBNP (33ng/L, 105 to171ng/L, p=0.6), LVEF or ultrasound markers of congestion. No changes were observed on blood pressure, body weight or renal function. Conclusion A 48-hour suspension of diuretics increases left ventricular and atrial volumes in patients with HF, that can be identified by ultrasound. How these findings may be used to guide clinical practice requires further study.
No takes yet. Share an insight, caveat, or question.
Hunter et al. (2026) conducted an RCT in Heart failure (n=20). Temporary suspension (omission) of prescribed loop diuretics and mineralocorticoid receptor antagonist (MRA) vs. Usual prescribed loop diuretic and MRA regimen (with morning dose omitted on the day of study visit) was evaluated on Left ventricular end diastolic volume (LVEDV) and echocardiographic/ultrasound markers of congestion (MD 8.4 ml, 95% CI 0.8-16.0, p=0.03). Omission of diuretics for 48 hours increased LVEDV by 8.4 ml, LVESV by 5.7 ml, and LAV by 4.9 ml, with no change in ultrasound congestion markers.
Synapse has enriched 10 related papers. Consider them for comparative context: